HSF1 and breast cancer: Importantly, the NRF2–HSF1 axis was found to play an important role in MCF-7 malignancy, since interfering with NRF2-mediated HSF1 activation also suppressed the survival, migration and the expression of E-cadherin and N-cadherin, two markers of EMT in MCF7 breast cancer cells.